Health In Tech, Inc. (HIT)
NASDAQ: HIT · Real-Time Price · USD
1.040
+0.070 (7.23%)
At close: Jun 26, 2026, 4:00 PM EDT
1.060
+0.020 (1.92%)
After-hours: Jun 26, 2026, 6:49 PM EDT
Health In Tech Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Health In Tech stock have an average target of 4.00, which predicts an increase of 284.62% from the current stock price of 1.04.
Analyst Consensus: Buy
* Price targets were last updated on May 14, 2026.
Analyst Ratings
The average analyst rating for Health In Tech stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Reiterates $4 | Buy | Reiterates | $4 | +284.62% | May 14, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $4 | Buy | Reiterates | $4 | +284.62% | May 14, 2026 |
Financial Forecast
Revenue This Year
46.81M
from 33.33M
Increased by 40.45%
Revenue Next Year
78.52M
from 46.81M
Increased by 67.75%
EPS This Year
-0.06
from 0.02
EPS Next Year
0.14
from -0.06
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 47.8M | 80.1M |
| Avg | 46.8M | 78.5M |
| Low | 46.0M | 77.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | 43.5% | 71.2% |
| Avg | 40.5% | 67.8% |
| Low | 37.9% | 65.4% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | -0.06 | 0.14 |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.